Business Wire

WOVEN-PLANET-HOLDINGS

2.6.2022 04:02:12 CEST | Business Wire | Press release

Share
Toyota and Woven Planet Have Developed a New Portable Hydrogen Cartridge Prototype

TOYOTA MOTOR CORPORATION (“Toyota”) and its subsidiary, Woven Planet Holdings, Inc. ("Woven Planet"), have developed a working prototype of its portable hydrogen cartridge. This cartridge design will facilitate the everyday transport and supply of hydrogen energy to power a broad range of daily life applications in and outside of the home. Toyota and Woven Planet will conduct Proof of Concept (“PoC”) trials in various places, including Woven City, a human-centered smart city of the future currently being constructed in Susono City, Shizuoka Prefecture.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220601005081/en/

Toyota and Woven Planet are studying a number of viable pathways to carbon neutrality and consider hydrogen to be a promising solution. Hydrogen has significant advantages. Zero Carbon Dioxide (CO2) is emitted when hydrogen is used. Furthermore, when hydrogen is produced using renewable energy sources such as wind, solar, geothermal, and biomass, CO2 emissions are minimized during the production process as well. Hydrogen can be used to generate electricity in fuel cell systems and can also be used as a combustion fuel.

Together with ENEOS Corporation, Toyota and Woven Planet are working to build a comprehensive hydrogen-based supply chain aimed at expediting and simplifying production, transport, and daily usage. These trials will focus on meeting the energy needs of Woven City residents and those living in its surrounding communities.

Benefits of Using Hydrogen Cartridges

  • Portable, affordable, and convenient energy that makes it possible to bring hydrogen to where people live, work, and play without the use of pipes
    • Prototype dimensions: 400mm (16") in length x 180mm (7") in diameter
    • Target weight: 5 kg (11lbs)
  • Swappable for easy replacement and quick recharging
  • Volume flexibility allows for a broad variety of daily use applications*2
  • Small-scale infrastructure can meet energy needs in remote and non-electrified areas and be swiftly dispatched in the case of a disaster

Next Steps for the Hydrogen Cartridge

Today most hydrogen is generated from fossil fuels and used for industrial purposes such as fertilizer production and petroleum refining. To use hydrogen as an energy source in our homes and daily life, the technology must meet different safety standards and be adjusted to new environments. In the future, we expect hydrogen will be generated with very low carbon emissions and used in a wider variety of applications. The Japanese government is working on a range of studies to promote the safe early adoption of hydrogen and Toyota and its business partners are excited to offer cooperation and support.

Our goal is to help hydrogen become commonplace by making this clean form of energy safe, convenient, and affordable. By establishing the underlying supply chain, we hope to facilitate the flow of a larger volume of hydrogen and fuel more applications. Woven City will explore and test an array of energy applications using hydrogen cartridges including mobility, household applications, and many future possibilities we have yet to imagine. Together with inventors and those living within and around Woven City, we will continue to advance mobility over time by constantly developing more practical applications for hydrogen cartridges. In future Woven City demonstrations, we will continue to improve the hydrogen cartridge itself, making it increasingly easy to use and improving the energy density.

The ultimate goal of this project is to realize a carbon-neutral society where everyone can access clean energy, first in Japan and then throughout the world. Toyota and Woven Planet aim to develop best practices for incorporating clean hydrogen energy into daily life by conducting human-centered demonstrations in and around Woven City. These real-life experiences will help us learn how to best transform hydrogen into a familiar, well-used, and well-loved form of energy.

The portable hydrogen cartridge prototype will be showcased at Super Taikyu Series 2022 Round 2 at Fuji SpeedWay from June 3 to 5, 2022*3 . Our showcase is geared toward teaching people about how hydrogen energy works and helping them imagine the countless ways hydrogen can become a useful part of their daily lives.

*1 Specifications and design are subject to change. The target weight of a full tank (5kg) excludes a valve and protector. Multiple types of receptacles will be considered in the future based on further application research over time.
*2 When electricity is generated by a typical FC system, one hydrogen cartridge is assumed to generate enough electricity to operate a typical household microwave for approximately 3-4 hours (based on the assumption of using a future iteration, high-pressure hydrogen tank with an electricity output of approximately 3.3 kWh/unit).
*3 Our showcase will be on June 4 and June 5 only.

Video Links
English: https://youtu.be/poYJCJR-WRo
Japanese: https://youtu.be/85_6eMJofuY

About Toyota Motor Corporation

Toyota Motor Corporation (Toyota) (NYSE: TM) is the global mobility company that introduced the Prius hybrid-electric car in 1997 and the first mass-produced fuel cell sedan, Mirai, in 2014. Headquartered in Toyota City, Japan, Toyota has been making cars since 1937. Today, Toyota proudly employs 370,000 employees in communities around the world. Together, they build around 10 million vehicles per year in 28 countries and regions, from mainstream cars and premium vehicles to mini-vehicles and commercial trucks, and sell them in more than 170 countries and regions under the brands Toyota, Lexus, Daihatsu and Hino.

For more information, please visit https://global.toyota/en

About Woven Planet

Woven Planet is building the safest mobility in the world. A subsidiary of Toyota, Woven Planet innovates and invests in new technologies, software, and business models that transform how we live, work and move. With a focus on automated driving, smart cities, robotics and more, Woven Planet builds on Toyota's legacy of trust to deliver secure, connected, reliable, and sustainable mobility solutions for all.

Learn more at https://www.woven-planet.global/en

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release

SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag

Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release

Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a

Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release

Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op

GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release

GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc

Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 07:00:00 CET | Press release

Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new produ

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye